Tempest Therapeutics Earnings
NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.762-0.008 (-1.04%)
Market open · Delayed 15 min · as of Oct 9, 3:34 PM ET
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.32
Tempest Therapeutics earnings summary
Tempest Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.32.
Summary generated from market data by MetaCap's automated system. Methodology